BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32915672)

  • 1. Intraoperative marking of the tumour resection surface for improved radiation therapy planning in head and neck cancer: preclinical evaluation of a novel liquid fiducial marker.
    Steybe D; Russe MF; Ludwig U; Sprave T; Vach K; Semper-Hogg W; Schmelzeisen R; Voss PJ; Poxleitner P
    Dentomaxillofac Radiol; 2021 Mar; 50(3):20200290. PubMed ID: 32915672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of computed tomography settings in the context of visualization and discrimination of low dose injections of a novel liquid soft tissue fiducial marker in head and neck imaging.
    Steybe D; Poxleitner P; Voss PJ; Metzger MC; Schmelzeisen R; Bamberg F; Kim S; Russe MF
    BMC Med Imaging; 2021 Oct; 21(1):157. PubMed ID: 34702192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Liquid Fiducial Marker in Esophageal Cancer Image Guided Radiation Therapy: Technical Feasibility and Visibility on Imaging.
    Machiels M; Voncken FEM; Jin P; van Dieren JM; Bartels-Rutten A; Alderliesten T; Aleman BMP; van Hooft JE; Hulshof MCCM
    Pract Radiat Oncol; 2019 Nov; 9(6):e506-e515. PubMed ID: 31279938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer.
    De Roover R; Crijns W; Poels K; Peeters R; Draulans C; Haustermans K; Depuydt T
    Med Phys; 2018 May; 45(5):2205-2217. PubMed ID: 29537613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visibility of fiducial markers used for image-guided radiation therapy on optical coherence tomography for registration with CT: An esophageal phantom study.
    Jelvehgaran P; Alderliesten T; Weda JJA; de Bruin M; Faber DJ; Hulshof MCCM; van Leeuwen TG; van Herk M; de Boer JF
    Med Phys; 2017 Dec; 44(12):6570-6582. PubMed ID: 29023771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of MRI visibility and artifacts at 3T of liquid fiducial marker in a pancreas tissue-mimicking phantom.
    Schneider S; Jølck RI; Troost EGC; Hoffmann AL
    Med Phys; 2018 Jan; 45(1):37-47. PubMed ID: 29136287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of virtual and titanium clip marking of tumour resection margins for improved radiation planning in head and neck cancer surgery.
    Bittermann G; Ermer M; Voss P; Duttenhoefer F; Zimmerer R; Schmelzeisen R; Metzger MC
    Int J Oral Maxillofac Surg; 2015 Dec; 44(12):1468-73. PubMed ID: 26265065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BioXmark for high-precision radiotherapy in an orthotopic pancreatic tumor mouse model : Experiences with a liquid fiducial marker.
    Dobiasch S; Kampfer S; Burkhardt R; Schilling D; Schmid TE; Wilkens JJ; Combs SE
    Strahlenther Onkol; 2017 Dec; 193(12):1039-1047. PubMed ID: 28808749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Bioresorbable Fiducial for Head and Neck Cancer.
    Fischman V; Ivanovic V; Jalisi S
    Otolaryngol Head Neck Surg; 2020 Sep; 163(3):554-556. PubMed ID: 32427505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification and comparison of visibility and image artifacts of a new liquid fiducial marker in a lung phantom for image-guided radiation therapy.
    Scherman Rydhög J; Irming Jølck R; Andresen TL; Munck Af Rosenschöld P
    Med Phys; 2015 Jun; 42(6):2818-26. PubMed ID: 26127034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of Safety and Feasibility of Hydrogel Marking of the Pancreas-Duodenum Interface for Image Guided Radiation Therapy (IGRT) in a Porcine Model: Implications in IGRT for Pancreatic Cancer Patients.
    Rao AD; Shin EJ; Beck SE; Garrett C; Kim SH; Lee NJ; Liapi E; Wong J; Herman J; Narang A; Ding K
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):640-645. PubMed ID: 29680252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fiducial markers: can the urologist do better?
    Duncan C; Joon DL; Lawrentschuk N; Jenkins T; Schneider M; Khoo V; Chao M; Lawlor M; O'Meara R; Berry C; Viotto A; Brown K; Wada M; Foroudi F; Sengupta S
    World J Urol; 2019 Jul; 37(7):1281-1287. PubMed ID: 30288597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visibility and artifacts of gold fiducial markers used for image guided radiation therapy of pancreatic cancer on MRI.
    Gurney-Champion OJ; Lens E; van der Horst A; Houweling AC; Klaassen R; van Hooft JE; Stoker J; van Tienhoven G; Nederveen AJ; Bel A
    Med Phys; 2015 May; 42(5):2638-47. PubMed ID: 25979055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and guidelines for the use of an injectable fiducial marker (BioXmark
    Brown K; Ghita M; Prise KM; Butterworth KT
    F1000Res; 2023; 12():526. PubMed ID: 38799243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative evaluation of fiducial markers for radiotherapy imaging.
    Chan MF; Cohen GN; Deasy JO
    Technol Cancer Res Treat; 2015 Jun; 14(3):298-304. PubMed ID: 25230715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of a novel liquid fiducial marker for use in image guided radiotherapy of oesophageal cancer.
    de Blanck SR; Scherman-Rydhög J; Siemsen M; Christensen M; Baeksgaard L; Irming Jølck R; Specht L; Andresen TL; Persson GF
    Br J Radiol; 2018 Dec; 91(1092):20180236. PubMed ID: 29975152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The validity of surgical clips as radiographic markers for the tumour resection cavity in head and neck cancer treatment.
    Bittermann G; Voss P; Duttenhoefer F; Zimmerer R; Vach K; Metzger MC
    J Craniomaxillofac Surg; 2015 Jul; 43(6):758-62. PubMed ID: 25964005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy.
    Habermehl D; Henkner K; Ecker S; Jäkel O; Debus J; Combs SE
    J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i61-8. PubMed ID: 23824129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BioXmark® liquid fiducial markers for image-guided radiotherapy in muscle invasive bladder cancer: a safety and performance trial.
    de Ridder M; Gerbrandy LC; de Reijke TM; Hinnen KA; Hulshof MCCM
    Br J Radiol; 2020 Jul; 93(1111):20200241. PubMed ID: 32463291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of implanted gold fiducial markers with MV-CBCT image-guided IMRT for pancreatic tumours.
    Packard M; Gayou O; Gurram K; Weiss B; Thakkar S; Kirichenko A
    J Med Imaging Radiat Oncol; 2015 Aug; 59(4):499-506. PubMed ID: 25754023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.